Phase 3 trial (air-CF 1) measuring improvement in respiratory symptoms in patients with cystic fibrosis (CF) following treatment with aztreonam lysine for inhalation (AZLI)

被引：0
作者：
Retsch-Bogart, G. Z. [1 ]
Montgomery, B. [2 ]
Gibson, R. [3 ]
McCoy, K. [4 ]
Oermann, C. M. [5 ]
Cooper, P. [6 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Gilead Sci Inc, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Ohio State Univ, Columbus, OH 43210 USA
[5] Baylor Coll Med, Houston, TX 77030 USA
[6] Childrens Hosp, Westmead, NSW, Australia
来源：
PEDIATRIC PULMONOLOGY | 2007年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
308
引用
收藏
页码：310 / 311
页数：2
相关论文
共 17 条
[1]   AZTREONAM FOR INHALATION SOLUTION (AZLI) TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS (CF) AND CHRONIC PSEUDOMONAS AERUGINOSA (PA) INFECTION [J].
Accurso, F. J. ;
Fayon, M. ;
Sermet, I. ;
Lewis, S. ;
Bresnik, M. ;
Oermann, C. M. .
PEDIATRIC PULMONOLOGY, 2013, 48 :343-343
[2]   Effect of 28-Day Aztreonam for Inhalation Solution (AZLI) Therapy on Cystic Fibrosis (CF) Respiratory Pathogens. [J].
Braff, M. ;
Retsch-Bogart, G. ;
McCoy, K. ;
Lewis, S. ;
Henig, N. R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[3]   THE EFFECT OF BURKHOLDERIA COLONY MORPHOLOGY IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES IN A RANDOMIZED TRIAL OF AZTREONAM FOR INHALATION SOLUTION (AZLI) [J].
Burns, J. L. ;
LiPuma, J. ;
McKevitt, M. ;
Lewis, S. ;
Retsch-Bogart, G. Z. ;
Bresnik, M. ;
Henig, N. R. ;
Tullis, E. .
PEDIATRIC PULMONOLOGY, 2012, 47 :333-333
[4]   AZTEC-CF STUDY: AZTREONAM LYSINE FOR INHALATION IN THE TREATMENT OF PULMONARY EXACERBATIONS OF CYSTIC FIBROSIS [J].
Frost, F. ;
Nazareth, D. ;
Walshaw, M. .
PEDIATRIC PULMONOLOGY, 2018, 53 :330-330
[5]   Hospitalization Risk of Current Standard of Care (SOC) vs Aztreonam for Inhalation Solution (AZLI) in Patients with Cystic Fibrosis (CF) [J].
Montgomery, A. B. ;
Lewis, S. ;
Higuchi, K. ;
Marshall, B. ;
Oermann, C. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[6]   LUNG FUNCTION IMPROVEMENT WITH AZTREONAM FOR INHALATION SOLUTION (AZLI) IN THE SINGLE-ARM EXTENSION OF A RANDOMIZED TRIAL OF INHALED ANTIPSEUDOMONAL ANTIBIOTICS IN PATIENTS WITH CYSTIC FIBROSIS (CF) AND PSEUDOMONAS AERUGINOSA INFECTION [J].
Assael, B. M. ;
Chiron, R. ;
Fischer, R. ;
Bresnik, M. ;
Lewis, S. ;
Pressler, T. ;
Oermann, C. M. .
PEDIATRIC PULMONOLOGY, 2011, :312-312
[7]   LUNG FUNCTION IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA (BURK) SPECIES INFECTION OVER THE COURSE OF A PROSPECTIVE, RANDOMIZED TRIAL OF AZTREONAM FOR INHALATION SOLUTION (AZLI) [J].
Tullis, E. ;
Burns, J. L. ;
Retsch-Bogart, G. Z. ;
Bresnik, M. ;
Lewis, S. ;
LiPuma, J. .
PEDIATRIC PULMONOLOGY, 2012, 47 :334-334
[8]   EFFECTS OF CONTINUOUS AZTREONAM FOR INHALATION SOLUTION (AZLI) USE ON PATHOGENS AND ANTIBIOTIC SUSCEPTIBILITY IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES INFECTION [J].
Tullis, E. ;
LiPuma, J. J. ;
Retsch-Bogart, G. ;
Bresnik, M. ;
Henig, N. ;
McKevitt, M. ;
Lewis, S. ;
Burns, J. L. .
PEDIATRIC PULMONOLOGY, 2011, :305-305
[9]   AZTREONAM FOR INHALATION SOLUTION (AZLI) IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES (BURK) INFECTION: INITIAL RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL [J].
Tullis, E. ;
Burns, J. L. ;
Retsch-Bogart, G. ;
Bresnik, M. ;
Henig, N. R. ;
Lewis, S. ;
LiPuma, J. J. .
PEDIATRIC PULMONOLOGY, 2011, :296-296
[10]   Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB) [J].
Barker, Alan ;
O'Donnell, Anne ;
Thompson, Philip J. ;
Flume, Patrick ;
Ruzi, Jonathan ;
de Gracia, Javier ;
Boersma, Wim ;
Polverino, Eva ;
Shao, Lixin ;
Zhang, Jenny ;
Leitzinger, Sheila ;
Haas, Laura ;
McKevitt, Matt ;
Montgomery, A. Bruce ;
Quittner, Alexandra ;
Gossage, David ;
O'Riordan, Thomas .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12